2012
DOI: 10.1016/j.abb.2012.09.014
|View full text |Cite
|
Sign up to set email alerts
|

Transcriptional and translational regulation of cytokine signaling in inflammatory β-cell dysfunction and apoptosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
20
0

Year Published

2014
2014
2018
2018

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 32 publications
(21 citation statements)
references
References 237 publications
1
20
0
Order By: Relevance
“…Development of type 1 diabetes mellitus is associated with a progressive cellular dysfunction and damage, leading ultimately to b-cell death (Eizirik & Mandrup-Poulsen 2001, Novotny et al 2012. As shown in previous studies, many steps in this process are mediated by ROS including also interactions with nitric oxide (Gurgul-Convey et al 2011).…”
Section: Discussionmentioning
confidence: 99%
“…Development of type 1 diabetes mellitus is associated with a progressive cellular dysfunction and damage, leading ultimately to b-cell death (Eizirik & Mandrup-Poulsen 2001, Novotny et al 2012. As shown in previous studies, many steps in this process are mediated by ROS including also interactions with nitric oxide (Gurgul-Convey et al 2011).…”
Section: Discussionmentioning
confidence: 99%
“…Chronic exposure to elevated IL-1 causes beta cell death and dysfunction due to altered gene transcription, changes in protein activity, and induction of oxidative stress (25). Data from clinical studies suggest that anti-IL-1 agents can improve beta cell function without affecting insulin sensitivity (17).…”
Section: Discussionmentioning
confidence: 99%
“…Data represent means ± SEM of four to six mice per group. *p<0.05, **p<0.01, ***p<0.001 Discussion Chronic exposure to elevated IL-1 causes beta cell death and dysfunction due to altered gene transcription, changes in protein activity and induction of oxidative stress [22]. Data from clinical studies suggest that anti-IL-1 agents can improve beta cell function without affecting insulin sensitivity [12].…”
Section: Il-1ra Limits Islet Amyloid Formation In Lean A-hiappmentioning
confidence: 99%